Accessibility Menu
Coloplast A/s logo

Coloplast A/s

(OTC) CLPBY

Current Price$6.04
Market Cap$12.52B
Since IPO (2014)+6%
5 Year-58%
1 Year-33%
1 Month+2%

Coloplast A/s Financials at a Glance

Market Cap

$12.52B

Revenue (TTM)

DKK 26.54B

Net Income (TTM)

DKK 2.07B

EPS (TTM)

$0.14

P/E Ratio

41.89

Dividend

$0.36

Beta (Volatility)

0.57 (Low)

Price

$6.04

Volume

265,929

Open

$5.97

Previous Close

$6.04

Daily Range

$5.97 - $6.07

52-Week Range

$5.64 - $10.03

Estimated Earnings Date

Aug 18, 2026

CLPBY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Coloplast A/s

Industry

Healthcare Equipment and Supplies

Employees

16,907

CEO

Lars Søren Rasmussen, MBA

Headquarters

Humlebæk, 3050, DK

CLPBY Financials

Key Financial Metrics (TTM)

Gross Margin

58.60%

Operating Margin

26.47%

Net Income Margin

7.51%

Return on Equity

14.23%

Return on Capital

18.38%

Return on Assets

4.51%

Earnings Yield

2.39%

Dividend Yield

5.96%

Payout Ratio

2.46%

Stock Overview

Market Cap

$12.52B

Shares Outstanding

2.07B

Volume

265.93K

Avg. Volume

533.38K

Financials (TTM)

Gross Profit

DKK 17.24B

Operating Income

DKK 7.42B

EBITDA

DKK 11.88B

Operating Cash Flow

DKK 7.61B

Capital Expenditure

-DKK 1.57B

Free Cash Flow

DKK 6.04B

Cash & ST Invst.

DKK 1.07B

Total Debt

DKK 24.25B

Coloplast A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

DKK 7.20B

+3.9%

Gross Profit

DKK 3.09B

-34.6%

Gross Margin

42.95%

N/A

Market Cap

$12.52B

N/A

Market Cap/Employee

$748.16K

N/A

Employees

16,741

N/A

Net Income

-DKK 987.14M

-208.2%

EBITDA

DKK 5.23B

+143.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

DKK 1.07B

+46.5%

Total Debt

DKK 24.25B

-0.0%

Accounts Receivable

DKK 4.98B

-9.3%

Inventory

DKK 3.95B

+3.9%

Long Term Debt

DKK 22.02B

+27.1%

Short Term Debt

DKK 2.23B

-67.8%

Return on Assets

4.51%

N/A

Return on Invested Capital

18.25%

N/A

Free Cash Flow

DKK 1.07B

+148.8%

Operating Cash Flow

DKK 1.48B

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBHMYSino Biopharmaceutical Limited
$12.68+0.00%
SUVPFSartorius AG
$243.82+0.00%
TRUMFTerumo Corporation
$13.07+0.38%
WXIBFWuXi Biologics (Cayman) Inc.
$4.68+17.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$20.58+0.00%
INTCIntel
$120.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About CLPBY

What is the current price of Coloplast A/s?

Coloplast A/s is trading at $6.04 per share.

What is the 52-week range for Coloplast A/s?

Over the past 52 weeks, Coloplast A/s has traded between $5.64 and $10.03.

How much debt does Coloplast A/s have?

As of the most recent reporting period, Coloplast A/s reported total debt of DKK 3.74B.

How much cash does Coloplast A/s have on hand?

Coloplast A/s reported DKK 164.52M in cash and cash equivalents in its most recent financial results.

What is Coloplast A/s’s dividend yield?

Coloplast A/s currently has a dividend yield of 5.96%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.